Heather Behanna

Principal at SR One, Ltd

Heather is currently a Principal at SR One, Ltd, focused on investments in innovative Biopharma companies. She joined SR One in the Spring of 2019, and has been involved in investments in MiroBio, Design Therapeutics and Dren Bio, where she is a board observer. Heather also serves on the board of Entasis Therapeutics. Previously, she worked as a Principal at Sofinnova Ventures, and prior to that, as an Equity Research Analyst at two boutique Investment Banks. Heather was formally a chemist at the Astellas Research Institute and Adjunct Faculty at Northwestern University. She received her Ph.D. in Chemistry at Northwestern University, MSc. in Organic Chemistry at the Weizmann Institute of Science, and BS from Tufts University.